Tag: Cancer: Skin
Remetinostat Gel Promising for Basal Cell Carcinoma
Overall response rate of 69.7 percent seen with topical HDAC inhibitor; complete resolution observed for 54.8 percent of tumors on pathologic exam
Certain Dermoscopic Structures Linked to Melanoma Detection
Odds for melanoma detection highest for presence of white structures, pseudopods, irregular pigmentation, blue-white veil, and peppering
Poll: Many ‘High-Risk’ Americans Unconcerned About Skin Cancer
AAD survey revealed that 49 percent of respondents were more worried about avoiding sunburn than preventing skin cancer
Barriers to Physician Skin Exam ID’d for Young Melanoma Survivors
Barriers to health care access linked to increased odds of suboptimal physician skin examination adherence
Second-Opinion Strategy Analyzed for Cutaneous Melanocytic Lesions
Decision-analytic model shows selective second-opinion strategy could increase diagnostic accuracy, decrease population-level costs
Many Americans Wrong About Sun’s Skin Cancer Dangers: Poll
Survey results show Generation Z and millennials have the greatest misunderstandings about sun exposure
Chronic Adverse Effects From Anti-PD-1 Immunotherapies Common
About 43 percent of patients who receive anti-PD1 therapy for advanced melanoma have chronic immune-related adverse effects
Fecal Transplant May Counter Anti-PD-1 Resistance in Melanoma
FMT plus anti-PD-1 therapy may change gut microbiome and help overcome drug resistance in some patients with advanced melanoma
Biomarker May Predict Treatment Outcome in Advanced Melanoma
Changes in plasma levels of ctDNA associated with survival outcomes in BRAF V600 mutation-positive unresectable or metastatic melanoma
ICI Need Not Be Withheld in Those With Autoimmune Disease
Objective response rates to anti-CTL4, anti-PD-1, combination similar for advanced melanoma patients with, without AID
